The devil we know: is the use of injectable agents for the treatment of MDR-TB justified? (2017)

First Author: Reuter A

Attributed to: A phase III cluster randomised placebo-controlled trial to assess the efficacy of preventive therapy in child and adolescent contacts of MDR-TB funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.5588/ijtld.17.0468

PubMed Identifier: 29037291

Publication URI: http://europepmc.org/abstract/MED/29037291

Type: Journal Article/Review

Volume: 21

Parent Publication: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Issue: 11

ISSN: 1027-3719